{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:00:54Z","timestamp":1784595654988,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.carrev.2025.07.004","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:28:00Z","timestamp":1752607680000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative efficacy and safety of latest generation ultrathin and thin biodegradable polymer vs. durable polymer drug-eluting stents in small vessel coronary artery disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4601-3416","authenticated-orcid":false,"given":"Sebastian","family":"Jaramillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Bittar","family":"de Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Alejandro","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana R.C.","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Garot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.carrev.2025.07.004_bb0005","doi-asserted-by":"crossref","first-page":"16812","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar","year":"2019","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.carrev.2025.07.004_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai","year":"2010","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2025.07.004_bb0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.5603\/CJ.a2020.0127","article-title":"Small vessel coronary artery disease: how small can we go with myocardial revascularization?","volume":"28","author":"Wybraniec","year":"2021","journal-title":"Cardiol J"},{"issue":"6","key":"10.1016\/j.carrev.2025.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","article-title":"Angiographic and clinical outcome following coronary stenting of small vessels","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2025.07.004_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/clc.24000","article-title":"Long-term outcomes after stent implantation in very small vessel coronary artery disease","volume":"46","author":"Liu","year":"2023","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2018:8:2","article-title":"The newest generation of drug-eluting stents and beyond","volume":"13","author":"Lee","year":"2018","journal-title":"Eur Cardiol Rev."},{"key":"10.1016\/j.carrev.2025.07.004_bb0035","first-page":"145(3)","article-title":"ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"2021","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.carrev.2025.07.004_bb0040","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Long-term clinical outcomes with Sirolimus-eluting coronary stents","volume":"50","author":"Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021078","article-title":"Coatings for cardiovascular stents\u2014an up-to-date review","volume":"25","author":"Udri\u0219te","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15420\/usc.2019.4.1","article-title":"Role of drug-coated balloons in small-vessel coronary artery disease","volume":"13","author":"Megaly","year":"2019","journal-title":"US Cardiol Rev"},{"issue":"13","key":"10.1016\/j.carrev.2025.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jcin.2022.05.028","article-title":"Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent","volume":"15","author":"Nakamura","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2025.07.004_bb0060","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCA.0000000000000949","article-title":"Ultrathin biodegradable polymer sirolimus-eluting stent versus contemporary durable polymer everolimus-eluting stent for percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"32","author":"Sethi","year":"2021","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43044-024-00522-1","article-title":"Comparison of long-term clinical outcomes of bioabsorbable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis","volume":"76","author":"Rehman","year":"2024","journal-title":"Egypt Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0070","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41598-022-26654-5","article-title":"Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta-analysis","volume":"13","author":"Yin","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.carrev.2025.07.004_bb0075","year":"2024","journal-title":"Cochrane"},{"key":"10.1016\/j.carrev.2025.07.004_bb0080","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2025.07.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2025.07.004_bb0090","series-title":"Version 5.4 for Mac","author":"Review Manager (RevMan)","year":"2020"},{"issue":"10205","key":"10.1016\/j.carrev.2025.07.004_bb0095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"The Lancet."},{"issue":"10119","key":"10.1016\/j.carrev.2025.07.004_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(17)33103-3","article-title":"A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial","volume":"391","author":"De Winter","year":"2018","journal-title":"The Lancet."},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0105","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.4244\/EIJV12I2A30","article-title":"Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial","volume":"12","author":"W\u00f6hrle","year":"2016","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.carrev.2025.07.004_bb0110","article-title":"Comparison of ultrathin, bioresorbable-polymer sirolimus-eluting stents and thin, durable-polymer everolimus-eluting stents in calcified or small vessel lesions","volume":"13","author":"K","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2025.07.004_bb0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamacardio.2019.1776","article-title":"Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: A Prespecified analysis of the randomized BIO-RESORT trial","volume":"4","author":"Buiten","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"10175","key":"10.1016\/j.carrev.2025.07.004_bb0120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(18)32467-X","article-title":"Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial","volume":"393","author":"Zaman","year":"2019","journal-title":"The Lancet."},{"issue":"10153","key":"10.1016\/j.carrev.2025.07.004_bb0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(18)31649-0","article-title":"Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET all comers): a multicentre, open-label, randomised non-inferiority trial","volume":"392","author":"Lansky","year":"2018","journal-title":"The Lancet."},{"issue":"9960","key":"10.1016\/j.carrev.2025.07.004_bb0130","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"The Lancet."},{"issue":"17","key":"10.1016\/j.carrev.2025.07.004_bb0135","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jcin.2019.05.001","article-title":"2-year clinical outcomes of an abluminal groove\u2013filled biodegradable-polymer sirolimus-eluting stent compared with a durable-polymer everolimus-eluting stent","volume":"12","author":"Xu","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2025.07.004_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcin.2020.12.011","article-title":"Biodegradable- versus durable-polymer drug-eluting stents for STEMI","volume":"14","author":"Pilgrim","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.carrev.2025.07.004_bb0145","doi-asserted-by":"crossref","first-page":"e1366","DOI":"10.4244\/EIJ-D-18-00944","article-title":"Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial","volume":"15","author":"Katagiri","year":"2020","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.carrev.2025.07.004_bb0150","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcin.2020.01.230","article-title":"Thin composite-wire-strut Zotarolimus-eluting stents versus ultrathin-strut Sirolimus-eluting stents in BIONYX at 2 years","volume":"13","author":"Buiten","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.carrev.2025.07.004_bb0155","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jcin.2018.04.014","article-title":"Comparison of a novel biodegradable polymer Sirolimus-eluting stent with a durable polymer Everolimus-eluting stent","volume":"11","author":"Lef\u00e8vre","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.carrev.2025.07.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008024","article-title":"Long-term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention: a subgroup analysis of the BIOSCIENCE randomized trial","volume":"12","author":"Iglesias","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"10416","key":"10.1016\/j.carrev.2025.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(23)02197-9","article-title":"Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial","volume":"402","author":"Iglesias","year":"2023","journal-title":"The Lancet."},{"issue":"10","key":"10.1016\/j.carrev.2025.07.004_bb0170","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.4244\/EIJ-D-23-00409","article-title":"Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET all comers randomised clinical trial","volume":"19","author":"Lansky","year":"2023","journal-title":"EuroIntervention"},{"issue":"18","key":"10.1016\/j.carrev.2025.07.004_bb0175","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jcin.2022.07.027","article-title":"Ultrathin Bioresorbable polymer Sirolimus-eluting stents versus durable polymer Everolimus-eluting stents","volume":"15","author":"Kandzari","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"10149","key":"10.1016\/j.carrev.2025.07.004_bb0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.carrev.2025.07.004_bb0185","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.4244\/EIJ-D-18-01214","article-title":"BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months","volume":"15","author":"Saito","year":"2019","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.carrev.2025.07.004_bb0190","article-title":"Small vessel coronary artery disease: rationale for standardized definition and critical appraisal of the literature","volume":"1","author":"Sanz-S\u00e1nchez","year":"2022","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(97)00511-1","article-title":"Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries","volume":"31","author":"Savage","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2025.07.004_bb0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.79.3.215","article-title":"How to treat small coronary vessels with angioplasty","volume":"79","author":"Meier","year":"1998","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0735-1097(99)00181-3","article-title":"Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization","volume":"34","author":"Schunkert","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13019-022-01812-y","article-title":"Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach","volume":"17","author":"Hassan","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.carrev.2025.07.004_bb0215","doi-asserted-by":"crossref","first-page":"1003322","DOI":"10.3389\/fbioe.2022.1003322","article-title":"Hypersensitivity and in-stent restenosis in coronary stent materials","volume":"10","author":"Hu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"23","key":"10.1016\/j.carrev.2025.07.004_bb0220","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.jcin.2017.06.059","article-title":"Endothelial barrier protein expression in biodegradable polymer Sirolimus-eluting versus durable polymer Everolimus-eluting metallic stents","volume":"10","author":"Mori","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.07.004_bb0225","article-title":"Vascular healing after biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents in chronic total occlusions","author":"Wang","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2025.07.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006741","article-title":"Unselected use of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for coronary revascularization","volume":"11","author":"Yamaji","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.17925\/HI.2019.13.2.17","article-title":"A review of the ultrathin Orsiro biodegradable polymer drug-eluting stent in the treatment of coronary artery disease","volume":"13","author":"Wu","year":"2019","journal-title":"Heart Int"},{"issue":"12","key":"10.1016\/j.carrev.2025.07.004_bb0240","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/hrt.2006.113860","article-title":"Coronary stenting: why size matters","volume":"93","author":"De Benedetti","year":"2006","journal-title":"Heart"},{"issue":"24","key":"10.1016\/j.carrev.2025.07.004_bb0245","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.jcin.2020.09.014","article-title":"Target lesion failure with current drug-eluting stents","volume":"13","author":"Taglieri","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.15420\/ecr.2008.4.2.82","article-title":"Biodegradable stents \u2013 a new era?","volume":"4","author":"S","year":"2008","journal-title":"Eur Cardiol Rev."},{"issue":"10","key":"10.1016\/j.carrev.2025.07.004_bb0255","doi-asserted-by":"crossref","first-page":"e792","DOI":"10.4244\/EIJ-E-23-00049","article-title":"Polymers, thickness, dosage: just pieces of the whole puzzle","volume":"19","author":"Paradies","year":"2023","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.carrev.2025.07.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001394","article-title":"Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis","volume":"7","author":"Monjur","year":"2020","journal-title":"Open Heart"},{"issue":"20","key":"10.1016\/j.carrev.2025.07.004_bb0265","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: Meta-analysis of randomized trials","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.07.004_bb0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ahj.2021.02.009","article-title":"Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from 5 randomized trials","volume":"235","author":"Pilgrim","year":"2021","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2025.07.004_bb0275","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10554-019-01580-2","article-title":"Early vessel healing after implantation of biodegradable-polymer and durable-polymer drug-eluting stent: 3-month angioscopic evaluation of the RESTORE registry","volume":"35","author":"Suzuki","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.carrev.2025.07.004_bb0280","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4244\/EIJV8I6A114","article-title":"Vascular responses to a biodegradable polymer (polylactic acid) based Biolimus A9-eluting stent in porcine models","volume":"8","author":"Hagiwara","year":"2012","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.carrev.2025.07.004_bb0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s40001-024-01949-7","article-title":"Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up","volume":"29","author":"Hassan","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.carrev.2025.07.004_bb0290","first-page":"ehae589","article-title":"Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial","author":"Taniwaki","year":"2024","journal-title":"Eur Heart J."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:34:05Z","timestamp":1774139645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925003562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"alternative-id":["S1553838925003562"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.07.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of latest generation ultrathin and thin biodegradable polymer vs. durable polymer drug-eluting stents in small vessel coronary artery disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}